TY - JOUR
T1 - Non-Pharmacologic Interventions for Older Adults with Subjective Cognitive Decline
T2 - Systematic Review, Meta-Analysis, and Preliminary Recommendations
AU - Smart, Colette M.
AU - Karr, Justin E.
AU - Areshenkoff, Corson N.
AU - Rabin, Laura A.
AU - Hudon, Carol
AU - Gates, Nicola
AU - Ali, Jordan I.
AU - Arenaza-Urquijo, Eider M.
AU - Buckley, Rachel F.
AU - Chetelat, Gael
AU - Hampel, Harald
AU - Jessen, Frank
AU - Marchant, Natalie L.
AU - Sikkes, Sietske A.M.
AU - Tales, Andrea
AU - van der Flier, Wiesje M.
AU - Wesselman, Linda
N1 - Publisher Copyright:
© 2017, Springer Science+Business Media New York.
PY - 2017/9/1
Y1 - 2017/9/1
N2 - In subjective cognitive decline (SCD), older adults present with concerns about self-perceived cognitive decline but are found to have clinically normal function. However, a significant proportion of those adults are subsequently found to develop mild cognitive impairment, Alzheimer’s dementia or other neurocognitive disorder. In other cases, SCD may be associated with mood, personality, and physical health concerns. Regardless of etiology, adults with SCD may benefit from interventions that could enhance current function or slow incipient cognitive decline. The objective of this systematic review and meta-analysis, conducted in accordance with the PRISMA guidelines, is to examine the benefits of non-pharmacologic intervention (NPI) in persons with SCD. Inclusion criteria were studies of adults aged 55 + with SCD defined using published criteria, receiving NPI or any control condition, with cognitive, behavioural, or psychological outcomes in controlled trails. Published empirical studies were obtained through a standardized search of CINAHL Complete, Cochrane Central Register of Controlled Trials, MEDLINE with Full Text, PsycINFO, and PsycARTICLES, supplemented by a manual retrieval of relevant articles. Study quality and bias was determined using PEDro. Nine studies were included in the review and meta-analysis. A wide range of study quality was observed. Overall, a small effect size was found on cognitive outcomes, greater for cognitive versus other intervention types. The available evidence suggests that NPI may benefit current cognitive function in persons with SCD. Recommendations are provided to improve future trials of NPI in SCD.
AB - In subjective cognitive decline (SCD), older adults present with concerns about self-perceived cognitive decline but are found to have clinically normal function. However, a significant proportion of those adults are subsequently found to develop mild cognitive impairment, Alzheimer’s dementia or other neurocognitive disorder. In other cases, SCD may be associated with mood, personality, and physical health concerns. Regardless of etiology, adults with SCD may benefit from interventions that could enhance current function or slow incipient cognitive decline. The objective of this systematic review and meta-analysis, conducted in accordance with the PRISMA guidelines, is to examine the benefits of non-pharmacologic intervention (NPI) in persons with SCD. Inclusion criteria were studies of adults aged 55 + with SCD defined using published criteria, receiving NPI or any control condition, with cognitive, behavioural, or psychological outcomes in controlled trails. Published empirical studies were obtained through a standardized search of CINAHL Complete, Cochrane Central Register of Controlled Trials, MEDLINE with Full Text, PsycINFO, and PsycARTICLES, supplemented by a manual retrieval of relevant articles. Study quality and bias was determined using PEDro. Nine studies were included in the review and meta-analysis. A wide range of study quality was observed. Overall, a small effect size was found on cognitive outcomes, greater for cognitive versus other intervention types. The available evidence suggests that NPI may benefit current cognitive function in persons with SCD. Recommendations are provided to improve future trials of NPI in SCD.
KW - Alzheimer’s disease
KW - Cognitive interventions
KW - Complementary therapies
KW - Mild cognitive impairment
KW - Treatment outcome
UR - http://www.scopus.com/inward/record.url?scp=85014580325&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85014580325&partnerID=8YFLogxK
U2 - 10.1007/s11065-017-9342-8
DO - 10.1007/s11065-017-9342-8
M3 - Review article
C2 - 28271346
AN - SCOPUS:85014580325
SN - 1040-7308
VL - 27
SP - 245
EP - 257
JO - Neuropsychology Review
JF - Neuropsychology Review
IS - 3
ER -